Intuitive Surgical (ISRG)
(Real Time Quote from BATS)
$483.17 USD
-1.23 (-0.25%)
Updated Sep 25, 2024 10:36 AM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Company Summary
Headquartered Sunnyvale, CA, Intuitive Surgical Inc designs, manufactures and markets the da Vinci surgical system, Ion endoluminal system and related instruments and accessories. The da Vinci surgical system is an advanced robot-assisted surgical system. The surgical system comprises a surgeon’s console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging.
Intuitive Surgical’s robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The da Vinci System is powered by robotic technology which has provided the company with ...
Company Summary
Headquartered Sunnyvale, CA, Intuitive Surgical Inc designs, manufactures and markets the da Vinci surgical system, Ion endoluminal system and related instruments and accessories. The da Vinci surgical system is an advanced robot-assisted surgical system. The surgical system comprises a surgeon’s console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging.
Intuitive Surgical’s robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The da Vinci System is powered by robotic technology which has provided the company with a solid exposure to Mechatronics, Robotocs and Artificial Intelligence for healthcare. The system provides 3-D High Definition vision, which helps surgeons gain superior visual clarity of target tissue and anatomy.Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform that utilizes instruments and accessories for minimally invasive biopsies in the lung. The system can be used beyond surgery into diagnostic, endoluminal procedures as well.
It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies.
The company operates through three segments: Instruments and Accessories, Systems and Services.
2023 Results at a Glance
Intuitive Surgical’s 2023 revenues totaled $7.12 billion, up 14.5% from 2022.
The company’s Instruments & Accessories sales were $4.28 billion (60% of net revenues), Systems revenues were $1.68 billion (23.6%) and Services revenues grossed $1.17 billion (16.4%).
General Information
Intuitive Surgical, Inc
1020 KIFER ROAD
SUNNYVALE, CA 94086
Phone: 408-523-2100
Fax: 408-523-1390
Email: investor.relations@intusurg.com
Industry | Medical - Instruments |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 6/30/2024 |
Earnings Date | 10/17/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 1.65 |
Current Year EPS Consensus Estimate | 6.67 |
Estimated Long-Term EPS Growth Rate | 17.40 |
Earnings Date | 10/17/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 484.40 |
52 Week High | 496.18 |
52 Week Low | 254.85 |
Beta | 1.39 |
20 Day Moving Average | 1,168,874.38 |
Target Price Consensus | 487.65 |
4 Week | 0.43 |
12 Week | 10.39 |
YTD | 43.58 |
4 Week | -1.45 |
12 Week | 6.08 |
YTD | 19.46 |
Shares Outstanding (millions) | 355.35 |
Market Capitalization (millions) | 172,133.56 |
Short Ratio | NA |
Last Split Date | 10/6/2017 |
Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
Payout Ratio | 0.00 |
Change in Payout Ratio | 0.00 |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | 72.67 |
Trailing 12 Months | 76.40 |
PEG Ratio | 4.18 |
vs. Previous Year | 24.58% |
vs. Previous Quarter | 26.72% |
vs. Previous Year | 14.47% |
vs. Previous Quarter | 6.31% |
Price/Book | 11.63 |
Price/Cash Flow | 89.32 |
Price / Sales | 22.73 |
6/30/24 | 13.04 |
3/31/24 | 12.91 |
12/31/23 | 13.11 |
6/30/24 | 11.43 |
3/31/24 | 11.22 |
12/31/23 | 11.31 |
6/30/24 | 5.15 |
3/31/24 | 5.55 |
12/31/23 | 4.76 |
6/30/24 | 4.22 |
3/31/24 | 4.61 |
12/31/23 | 4.02 |
6/30/24 | 23.62 |
3/31/24 | 22.95 |
12/31/23 | 22.67 |
6/30/24 | 27.65 |
3/31/24 | 27.16 |
12/31/23 | 25.24 |
6/30/24 | 29.46 |
3/31/24 | 28.36 |
12/31/23 | 27.50 |
6/30/24 | 41.64 |
3/31/24 | 39.60 |
12/31/23 | 38.03 |
6/30/24 | 1.99 |
3/31/24 | 2.10 |
12/31/23 | 2.22 |
6/30/24 | 0.00 |
3/31/24 | 0.00 |
12/31/23 | 0.00 |
6/30/24 | 0.00 |
3/31/24 | 0.00 |
12/31/23 | 0.00 |